Scheduling nab-paclitaxel combined with gemcitabine as first line treatment for metastatic pancreatic adenocarcinoma

P G Corrie, W Qian, B Basu, Juan Valle, S Falk, C Iwuji, H Wasan, D Palmer, M Scott-Brown, J Wadsley, S Arif, J Bridgewater, D Propper, R Gillmore, A Gopinathan, R Skells, P Bundi, R Brais, K Dalchau, L BaxA Chhabra, A Machin, A Dayim, K McAdam, S Cummins, L Wall, R Ellis, A Anthoney, J Evans, Y T Ma, C Isherwood, A Neesse, D Tuveson, D I Jodrell

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Scheduling nab-paclitaxel combined with gemcitabine as first line treatment for metastatic pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science